AI-generated summary
The authors report a study of 20 patients with skin types I to III treated three times with a new 595-nm pulsed dye laser using a 10-mm beam and a two-pass protocol for purpura-free photorejuvenation. They report that most patients achieved over 90% reduction of fine telangiectasias and dark lentigines, with pigment improvement proportional to baseline pigment and mean textural improvement of 34%.
- Participants
- 20
- Who or what was studied
- Twenty patients with skin types I to III
- Wavelengths
- 595 nm
- Limits stated in the abstract
- The abstract describes a small uncontrolled case series evaluated by comparing photographs and live assessment, with no control group reported.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.